Rabies diagnostics Market Overview
Rabies is a life treating a viral disease which is caused by the biting of an infected rabid animal. It is fever, headache, muscle aches, loss of appetite, nausea, and tiredness to the infected animal or human. The surge in the prevalence of rabies, increasing awareness about rabies, and a rising number of pet animals are expected to drive the growth of the global rabies diagnostics market during the forecast period. Moreover, ongoing research and development activities by non-profit organizations and aggressive strategies by top players such as mergers, expansion, and collaboration for the development of new products and new product launches by major players are also boosting the rabies diagnostics market growth . According to the report published by World Organization for Animal Health, Asia-Pacific region is hugely affected by rabies owing to the increasing cases of rabies, in Asia approximately 31000 deaths were caused by rabies which is 56% of the total cases.
The high costs associated with the diagnostic, absence of awareness about rabies and scarcity of skilled workforce may hamper the growth of the market during the assessment period. The preferred vaccines for rabies pre-exposure vaccination and post-exposure therapy are HDCV (Human Diploid Cell Rabies Vaccine) and PCECV (Purified Chick Embryo Cell Vaccine) these uses rabies vaccines in india.
Global Rabies Diagnostics Market – Segmentation
The report is segmented into four dynamics to widen the scope of understanding,
- By Method : Fluorescent Antibody Test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, and Serology Tests, among others.
- By Technology : ELISA/Immunohistochemistry, Chromatography Techniques, and PCR, among others.
- By End-user : Hospitals, Diagnostic Centers, and Cancer Palliative Care Clinics, among others.
- By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World.
Rabies diagnostics Market Regional Analysis
The market is likely to dominate by Asia-Pacific during the forecast period owing to the improving healthcare infrastructure, increasing investments in the healthcare sector and expansions by market players in the region. Also, a country such as India and China are considering the fastest growing region due to a government focused toward adopting new technology, and the best treatment option from a developed country.
The Americas are expected to be the second-largest market in the global rabies diagnostics market due to the rising collaborative activities by major players, raising awareness about rabies, the involvement of non-profit organization to control rabies, and well-established healthcare infrastructure.
The European market is likely to hold a significant market share in the rabies diagnostics market. The government funding, well-established healthcare sector, and support of the healthcare sector coupled with increasing research and development are responsible for the growth of this market in the region.
Rabies diagnostics Market Competitive Landscape:
Some of the key players in the global rabies diagnostics market are Bio-Rad Laboratories, Inc., Merck KGaA, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote, Inc., Express Biotech International Inc., MyBioSource.com., and BioGen Technologies.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
